LRRK2 G2019S Mutation in Multiple System Atrophy, A Case Report

被引：0
|
作者：
Carrer, T.
Bonato, G.
Sandre, M.
Emmi, A.
Antonini, A.
机构：
来源：
MOVEMENT DISORDERS | 2023年 / 38卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
158
引用
收藏
页码：S66 / S66
页数：1
相关论文
共 50 条
  • [1] Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation
    Tommaso Carrer
    Giulia Bonato
    Michele Sandre
    Aron Emmi
    Marta Campagnolo
    Giulia Musso
    Miryam Carecchio
    Piero Parchi
    Angelo Antonini
    Neurological Sciences, 2024, 45 : 309 - 313
  • [2] Rapidly progressive multiple system atrophy in a patient carrying LRRK2 G2019S mutation
    Carrer, Tommaso
    Bonato, Giulia
    Sandre, Michele
    Emmi, Aron
    Campagnolo, Marta
    Musso, Giulia
    Carecchio, Miryam
    Parchi, Piero
    Antonini, Angelo
    NEUROLOGICAL SCIENCES, 2024, 45 (01) : 309 - 313
  • [3] Early-onset pathologically proven multiple system atrophy with LRRK2 G2019S mutation
    Riboldi, Giulietta Maria
    Palma, Jose-Alberto
    Cortes, Etty
    Iida, Megan A.
    Sikder, Tamjeed
    Henderson, Brooklyn
    Raj, Towfique
    Walker, Ruth H.
    Crary, John F.
    Kaufmann, Horacio
    Frucht, Steven
    MOVEMENT DISORDERS, 2019, 34 (07) : 1080 - 1082
  • [4] The G2019S LRRK2 Mutation is Rare in Korean Patients with Parkinson's Disease and Multiple System Atrophy
    Cho, Jin-Whan
    Kim, Sung-Yeon
    Park, Sung-Sup
    Jeon, Beom S.
    JOURNAL OF CLINICAL NEUROLOGY, 2009, 5 (01): : 29 - 32
  • [5] Prevalence of G2019S LRRK2 mutation in Brazil
    Munhoz, R. P.
    Teive, H. A. G.
    Raskin, S.
    Werneck, L. C.
    Sato, C.
    Moreno, D.
    Rogaeva, E.
    MOVEMENT DISORDERS, 2008, 23 (01) : S48 - S48
  • [6] Clinical heterogeneity of the LRRK2 G2019S mutation
    Papapetropoulos, Spiridon
    Singer, Carlos
    Ross, Owen A.
    Toft, Mathias
    Johnson, Joseph L.
    Farrer, Matthew J.
    Mash, Deborah C.
    ARCHIVES OF NEUROLOGY, 2006, 63 (09) : 1242 - 1246
  • [7] Analysis of the LRRK2 G2019S mutation in Alzheimer disease
    Zabetian, CP
    Lauricella, CJ
    Tsuang, DW
    Leverenz, JB
    Schellenberg, GD
    Payami, H
    ARCHIVES OF NEUROLOGY, 2006, 63 (01) : 156 - 157
  • [8] Olfactory dysfunction in LRRK2 G2019S mutation carriers
    Saunders-Pullman, R.
    Stanley, K.
    Wang, C.
    San Luciano, M.
    Shanker, V.
    Hunt, A.
    Severt, L.
    Raymond, D.
    Ozelius, L. J.
    Lipton, R. B.
    Bressman, S. B.
    NEUROLOGY, 2011, 77 (04) : 319 - 324
  • [9] Transcranial sonography in LRRK2 G2019S mutation carriers
    Vilas, D.
    Ispierto, L.
    Alvarez, R.
    Pont-Sunyer, C.
    Marti, M. J.
    Vall-deoriola, F.
    Compta, Y.
    De Fabregues, O.
    Hernandez-Vara, J.
    Puente, V.
    Calopa, M.
    Jauma, S.
    Campdelacreu, J.
    Aguilar, M.
    Quilez, P.
    Casquero, P.
    Lomena, F.
    Tolosa, E.
    MOVEMENT DISORDERS, 2015, 30 : S25 - S25
  • [10] LRRK2 mRNA and protein expression in Parkinson's disease cases with LRRK2 G2019S mutation
    Sharma, S.
    Bandopadhyay, R.
    Kingsbury, A. E.
    Lashley, T. C.
    Lees, A. J.
    Revesz, T.
    Wood, N. W.
    Holton, J. L.
    NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY, 2009, 35 : 27 - 28
12345